James F Trotter
Overview
Explore the profile of James F Trotter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
140
Citations
2510
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Finotti M, Wall A, DAlessandro A, Schwartz G, Sonnenday C, Goldberg D, et al.
Hepatobiliary Surg Nutr
. 2024 Nov;
13(5):824-836.
PMID: 39507724
Despite a significant increase in utilization over the past decade, the number of donation after circulatory death (DCD) organs that are procured and transplanted in the United States (US) remains...
2.
Gonzalez S, Shankar N, Mehta A, Garcia-Saenz-de-Sicilia M, Klintmalm G, Trotter J, et al.
Liver Transpl
. 2024 Sep;
PMID: 39311856
Kidney dysfunction is associated with decreased survival in liver transplant (LT) candidates, yet serum creatinine (sCr) is a poor surrogate for glomerular filtration rate (GFR) in this population. Serum cystatin...
3.
Wall A, da Graca B, Asrani S, Ruiz R, Fernandez H, Gupta A, et al.
Liver Transpl
. 2024 Jan;
30(8):775-784.
PMID: 38190240
Donation after circulatory death (DCD) donors now represent over 30% of the deceased donor pool in the United States. Compared to donation after brain death, DCD is less likely to...
4.
Mehta S, Trotter J
Liver Transpl
. 2023 Aug;
29(12):1330-1331.
PMID: 37526925
No abstract available.
5.
Sanyal A, Ratziu V, Loomba R, Anstee Q, Kowdley K, Rinella M, et al.
J Hepatol
. 2023 Jul;
79(5):1110-1120.
PMID: 37517454
Background & Aims: Obeticholic acid (OCA) is a first-in-class farnesoid X receptor agonist and antifibrotic agent in development for the treatment of pre-cirrhotic liver fibrosis due to non-alcoholic steatohepatitis (NASH)....
6.
7.
8.
9.
Asrani S, Saracino G, Wall A, Trotter J, Testa G, Hernaez R, et al.
Am J Transplant
. 2022 Sep;
22(12):2921-2930.
PMID: 36053559
Accurate assessment of donor quality at the time of organ offer for liver transplantation candidates may be inadequately captured by the donor risk index (DRI). We sought to develop and...
10.
Klintmalm G, Trotter J, Demetris A
Transplant Direct
. 2022 Jul;
8(7):e1076.
PMID: 35774420
Methods: Herein, we report an illustrative case of a young 20-y-old otherwise healthy woman who underwent liver replacement for Alagille's syndrome from an ABO-compatible, 6 antigen-mismatched crossmatch-negative 24-y-old man. Although...